Funding

QuberTech

United Kingdom · Biotech · Agritech · Climate tech

Develops sustainable natural rubber from engineered dandelions using controlled-environment biotech

Visit qubertech.ukFunding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Seed£3.4MDefra — Role not disclosedInnovate UK — Role not disclosedUKI2S (managed by Future Planet Capital) — Role not disclosed

Investors

DefraSeedInnovate UKSeedUKI2S (managed by Future Planet Capital)Seed

Coverage

May 20, 2026QuberTech · Seed

Similar companies

Pathos AIClinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.$237M · Series E
Star TherapeuticsBiotechnology company discovering and developing antibody therapies for diseases with significant unmet need.$200M · Private financing
iCUREXKagoshima medical-device company developing chitosan hydrogel materials for wound care, including the syringe-delivered Kitosla CX dressing.¥140M · Series A first close: equity and debt
Sourcesqubertech.uk ↗